Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Plus Tenofovir in Chronic Hepatitis B with Treatment Failure
NCT01063036Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of entecavir, tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started May 2010; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01063036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063036.